These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 27426886)
21. Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial. Mueller J Mov Disord; 2009 May; 24(7):1098-9; author reply 1100. PubMed ID: 18942082 [No Abstract] [Full Text] [Related]
22. Application of botulinum toxin to clinical therapy: advances and cautions. Levy NS; Lowenthal DT Am J Ther; 2012 Jul; 19(4):281-6. PubMed ID: 22481607 [TBL] [Abstract][Full Text] [Related]
23. Botulinum Toxin for Painful Torticollis in Leptomeningeal Disease: Case Report. Selby D; Nguyen M; Toor H J Pain Symptom Manage; 2018 May; 55(5):e7-e9. PubMed ID: 29191723 [No Abstract] [Full Text] [Related]
24. Perioperative use of botulinum toxins. Adler CH Toxicon; 2009 Oct; 54(5):654-7. PubMed ID: 19084551 [TBL] [Abstract][Full Text] [Related]
25. New botulinum toxin approved with REMS. Thompson CA Am J Health Syst Pharm; 2010 Sep; 67(18):1486. PubMed ID: 20811019 [No Abstract] [Full Text] [Related]
27. Botulinum toxin: from life-threatening disease to novel medical therapy. Mahajan ST; Brubaker L Am J Obstet Gynecol; 2007 Jan; 196(1):7-15. PubMed ID: 17240220 [TBL] [Abstract][Full Text] [Related]
28. Chronic eye movement induced pain and a possible role for its treatment with botulinum toxin. Burton BJ; Khan SR; Lee JP Br J Ophthalmol; 2003 Sep; 87(9):1194-5. PubMed ID: 12928305 [No Abstract] [Full Text] [Related]
29. A critical review of the use of botulinum toxin in orofacial pain disorders. Clark GT; Stiles A; Lockerman LZ; Gross SG Dent Clin North Am; 2007 Jan; 51(1):245-61, ix. PubMed ID: 17185069 [TBL] [Abstract][Full Text] [Related]
30. Goal attainment after treatment of parkinsonian camptocormia with botulinum toxin. Fietzek UM; Schroeteler FE; Ceballos-Baumann AO Mov Disord; 2009 Oct; 24(13):2027-8. PubMed ID: 19645067 [No Abstract] [Full Text] [Related]
31. Botulinum toxin: a new dimension in the treatment of lower urinary tract dysfunction. Rajkumar GN; Conn IG Urology; 2004 Jul; 64(1):2-8. PubMed ID: 15245922 [No Abstract] [Full Text] [Related]
32. Botox and Dysport are distinct. Madaliński M Endoscopy; 2000 Jun; 32(6):502-3. PubMed ID: 10863924 [No Abstract] [Full Text] [Related]
33. Dystonia and headaches: clinical features and response to botulinum toxin therapy. Galvez-Jimenez N; Lampuri C; Patiño-Picirrillo R; Hargreave MJ; Hanson MR Adv Neurol; 2004; 94():321-8. PubMed ID: 14509690 [No Abstract] [Full Text] [Related]
34. Fatal mediastinitis following botulinum toxin injection for esophageal spasm. Marjoux S; Pioche M; Benet T; Lanne JS; Roman S; Ponchon T; Mion F Endoscopy; 2013; 45 Suppl 2 UCTN():E405-6. PubMed ID: 24285073 [No Abstract] [Full Text] [Related]
36. Botulinum toxin for chronic pain: What's on the horizon? Dickison C; Leggit JC J Fam Pract; 2021 Nov; 70(9):442-449. PubMed ID: 34818151 [TBL] [Abstract][Full Text] [Related]
37. Botulinum toxin for the treatment of acute-onset concomitant esotropia in Chiari I malformation. Firth AY; Burke JP Br J Ophthalmol; 2007 Aug; 91(8):1094. PubMed ID: 17638829 [No Abstract] [Full Text] [Related]
38. Botulinum toxin. From poison to medical wonder. Mayo Clin Health Lett; 2006 Dec; 24(12):4-5. PubMed ID: 17310508 [No Abstract] [Full Text] [Related]
39. Updates on the antinociceptive mechanism hypothesis of botulinum toxin A. Aoki KR; Francis J Parkinsonism Relat Disord; 2011 Nov; 17 Suppl 1():S28-33. PubMed ID: 21999893 [TBL] [Abstract][Full Text] [Related]
40. Duration of effectiveness of botulinum toxin type B in the treatment of cervical dystonia. Lew MF Adv Neurol; 2004; 94():211-5. PubMed ID: 14509675 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]